Featured

The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP) formulations for delivering RNA-based medicines. This partnership, funded by a £10 million grant from Innovate...

A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as the need for and the strategy so as to update the composition based on evidence...

The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established by making use of approvals from Singapore, Canada, Japan, the US, Australia, Switzerland, and, of...

Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there happens to be a bifurcation of attitudes, with some researchers pretty much excited when it...

In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing disruptions in the global supply chain. The situation worsened in March 2021 when contamination issues...

The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...

A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as compared to the current methods. The approach could also go on to power advanced cell...